— Know what they know.
Not Investment Advice

PXS.L LSE

Provexis plc
1W: +15.0% 1M: -8.6% 3M: -23.2% YTD: -36.0% 1Y: +33.3% 3Y: +53.6% 5Y: +6.7%
£0.96 ($0.01)
+0.02 (+2.13%)
 
Weekly Expected Move ±9.5%
£1 £1 £1 £1 £1
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · £22.5M mcap · 1.81B float · 0.056% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap£22.5M ($0.3M)
52W Range0.00618-1.55
Volume863,741
Avg Volume1,013,263
Beta0.66
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOIan Ford
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2004-06-28
2 Blagrave Street
Reading, BR RG1 1AZ
GB
44 7490 391 888
About Provexis plc

Operating globally, Provexis plc, along with its associated companies, specializes in the creation, licensing, and commercialization of functional foods, medical nutritional products, and dietary supplements. A key offering is Fruitflow, a unique tomato extract designed to reduce the tendency for abnormal blood clot formation, which is linked to severe cardiovascular conditions such as heart attacks and strokes. This versatile extract is available in syrup and powder formats for integration into various food and beverage items, as well as dietary supplements. The company also provides Fruitflow + Omega-3, a capsule-based supplement aimed at fostering healthy blood circulation and supporting normal cardiac function. Provexis plc holds a strategic collaboration agreement with By-Health Co., Ltd. Its products are distributed through both physical retail channels and digital online platforms. Founded in 1999, Provexis plc has its headquarters situated in Reading, United Kingdom.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms